NewsBenzinga卡迪夫肿瘤学第三季度每股收益为$(0.12),高于预期的$(0.15);销售额为17.1万美元,高于预期的6.7857万美元。 卡迪夫肿瘤学第三季度每股收益为$(0.12),高于预期的$(0.15);销售额为17.1万美元,高于预期的6.7857万美元。 Benzinga 2026.11.12 12:17 (GMT+0) Open on Benzinga Other news Leerink Partners Initiates Coverage On Erasca with Outperform Rating, Announces Price Target of $35 What's Going on With AST SpaceMobile Stock on Monday? Reported November 16, U.S. CMS Issues Proposed Rule To Target Fraud Across Medicare, Medicaid/CHIP, And The Marketplace; Sees Possible Savings Of $90B Over Next 10 Years Stock of the Day: Is Pepsi About to Break Out? Intel Extends Slide as Nvidia Trims Stake 25%, Shareholder Suit Adds Pressure HC Wainwright & Co. Maintains Buy on Soluna Holdings, Lowers Price Target to $3
Reported November 16, U.S. CMS Issues Proposed Rule To Target Fraud Across Medicare, Medicaid/CHIP, And The Marketplace; Sees Possible Savings Of $90B Over Next 10 Years